178
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Fusogenic liposomal formulation of sirolimus: improvement of drug anti-proliferative effect on human T-cells

, &
Pages 1558-1565 | Received 23 Jun 2014, Accepted 26 Sep 2014, Published online: 14 Oct 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Wenjun Chen, Miao Guo & Shuli Wang. (2016) Anti prostate cancer using PEGylated bombesin containing, cabazitaxel loading nano-sized drug delivery system. Drug Development and Industrial Pharmacy 42:12, pages 1968-1976.
Read now
Amit Alexander, Swarnlata Saraf & Shailendra Saraf. (2015) A comparative study of chitosan and poloxamer based thermosensitive hydrogel for the delivery of PEGylated melphalan conjugates. Drug Development and Industrial Pharmacy 41:12, pages 1954-1961.
Read now

Articles from other publishers (9)

Clara Cortell-Fuster, María Amparo Martínez-Gómez, Ana Cristina Cercós-Lleti & Mónica Climente-Martí. (2023) Optimization, Formulation, and Stability of Topical Rapamycin Used for Rare Tuberous Sclerosis Disease: from Ointment to Liposomes. Journal of Pharmaceutical Innovation.
Crossref
Vahid Eskandari, Saeideh Mehmandoust, Zahra Farahani, Negin Poorbeik Mohammad & Amin Hadi. (2023) Liposomes/nanoliposomes and Surfaced-enhanced Raman Scattering (SERS): A review. Vibrational Spectroscopy 126, pages 103536.
Crossref
Aishwarya Shinde, Kanan Panchal, Sumeet Katke, Rishi Paliwal & Akash Chaurasiya. (2022) Tyrosine kinase inhibitors as next generation oncological therapeutics: Current strategies, limitations and future perspectives. Therapies 77:4, pages 425-443.
Crossref
Mahshid Deldar Abad Paskeh, Maliheh Entezari, Courtney Clark, Amirhossein Zabolian, Ehsan Ranjbar, Mahdi Vasheghani Farahani, Hossein Saleki, Seyed Omid Sharifzadeh, Fatemeh Bakhtiari Far, Milad Ashrafizadeh, Saeed Samarghandian, Haroon Khan, Saeid Ghavami, Ali Zarrabi & Marek J. Łos. (2022) Targeted regulation of autophagy using nanoparticles: New insight into cancer therapy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1868:3, pages 166326.
Crossref
Solmaz Mojarad-Jabali, Masoud Farshbaf, Paul R. Walker, Salar Hemmati, Yousef Fatahi, Parvin Zakeri-Milani, Muhammad Sarfraz & Hadi Valizadeh. (2021) An update on actively targeted liposomes in advanced drug delivery to glioma. International Journal of Pharmaceutics 602, pages 120645.
Crossref
Ahmed Gouda, Omar S. Sakr, Maha Nasr & Omaima Sammour. (2021) Ethanol injection technique for liposomes formulation: An insight into development, influencing factors, challenges and applications. Journal of Drug Delivery Science and Technology 61, pages 102174.
Crossref
Peihong Xiao, Juan Zhao, Yi Huang, Rongrong Jin, Zhonglan Tang, Ping Wang, Xu Song, Hongfei Zhu, Zibin Yang & Nie Yu. (2020) A Novel Long-circulating DOX Liposome: Formulation and Pharmacokinetics Studies. Pharmaceutical Nanotechnology 8:5, pages 391-398.
Crossref
Shahenda Ramadan, Salma N. Tammam, Maryam A. Shetab Boushehri, Hans-Georg Breitinger, Ulrike Breitinger, Samar Mansour & Alf Lamprecht. (2020) Liposomal delivery of functional transmembrane ion channels into the cell membranes of target cells; a potential approach for the treatment of channelopathies. International Journal of Biological Macromolecules 153, pages 1080-1089.
Crossref
Fahimeh Zahednezhad, Maryam Saadat, Hadi Valizadeh, Parvin Zakeri-Milani & Behzad Baradaran. (2019) Liposome and immune system interplay: Challenges and potentials. Journal of Controlled Release 305, pages 194-209.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.